Labiana Health (XMAD:LAB) Change In Inventory : €0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Change In Inventory?

Labiana Health's change in inventory for the quarter that ended in Dec. 2022 was €0.00 Mil. It means Labiana Health's inventory stayed the same from Jun. 2022 to Dec. 2022 .

Labiana Health's change in inventory for the fiscal year that ended in Dec. 2022 was €1.09 Mil. It means Labiana Health's inventory declined by €1.09 Mil from Dec. 2021 to Dec. 2022 .

Labiana Health's Total Inventories for the quarter that ended in Dec. 2022 was €13.83 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Labiana Health's Days Inventory for the quarter that ended in Dec. 2022 was 198.58.

Inventory Turnover measures how fast the company turns over its inventory within a year. Labiana Health's Inventory Turnover for the quarter that ended in Dec. 2022 was 0.92.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Labiana Health's Inventory-to-Revenue for the quarter that ended in Dec. 2022 was 0.54.

Labiana Health Change In Inventory Historical Data

The historical data trend for Labiana Health's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Change In Inventory Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Change In Inventory

-0.22

-0.85

1.09

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Change In Inventory	-	-	-	-

Labiana Health Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Labiana Health (XMAD:LAB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Labiana Health's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	15.657	/	14.389	*	365 / 2
	=	198.58

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Labiana Health's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.389	/	15.657
	=	0.92

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Labiana Health's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	15.657	/	28.787
	=	0.54

Labiana Health Change In Inventory Related Terms

Thank you for viewing the detailed overview of Labiana Health's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Change In Inventory

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.